Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

European survey on principles of prudent antibiotic prescribing teaching in undergraduate students.

Pulcini C, Wencker F, Frimodt-Møller N, Kern WV, Nathwani D, Rodríguez-Baño J, Simonsen GS, Vlahović-Palčevski V, Gyssens IC; ESGAP Curriculum Working Group.

Clin Microbiol Infect. 2015 Apr;21(4):354-61. doi: 10.1016/j.cmi.2014.11.015. Epub 2014 Nov 22.

PMID:
25658523
2.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Godman B, Malmström RE, Diogene E, Gray A, Jayathissa S, Timoney A, Acurcio F, Alkan A, Brzezinska A, Bucsics A, Campbell SM, Czeczot J, de Bruyn W, Eriksson I, Yusof FA, Finlayson AE, Fürst J, Garuoliene K, Guerra Júnior A, Gulbinovič J, Jan S, Joppi R, Kalaba M, Magnisson E, McCullagh L, Miikkulainen K, Ofierska-Sujkowska G, Pedersen HB, Selke G, Sermet C, Spillane S, Supian A, Truter I, Vlahović-Palčevski V, Vien LE, Vural EH, Wale J, Władysiuk M, Zeng W, Gustafsson LL.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. doi: 10.1586/17512433.2015.990380.

PMID:
25487078
3.

Quality indicators as a tool in improving the introduction of new medicines.

Campbell SM, Godman B, Diogene E, Fürst J, Gustafsson LL, MacBride-Stewart S, Malmström RE, Pedersen H, Selke G, Vlahović-Palčevski V, van Woerkom M, Wong-Rieger D, Wettermark B.

Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):146-57. doi: 10.1111/bcpt.12295. Epub 2014 Sep 19.

PMID:
25052464
4.

M-03: Enquête européenne sur les programmes d'enseignement des principes de bon usage des antibiotiques aux étudiants en médecine.

Pulcini C, Kern W, Nathwani D, Rodríguez Baño J, Simonsen GS, Vlahović-Palĉevski V, Gyssens IC.

Med Mal Infect. 2014 Jun;44(6 Suppl):66. doi: 10.1016/S0399-077X(14)70240-9. French. No abstract available.

PMID:
24994327
5.

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.

Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, Finlayson AE, Fürst J, Garuoliene K, Herholz H, Kalaba M, Laius O, Piessnegger J, Sermet C, Schwabe U, Vlahović-Palčevski VV, Markovic-Pekovic V, Vončina L, Malinowska K, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 17;5:106. doi: 10.3389/fphar.2014.00106. eCollection 2014. Review.

6.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Godman B, Malmström RE, Diogene E, Jayathissa S, McTaggart S, Cars T, Alvarez-Madrazo S, Baumgärtel C, Brzezinska A, Bucsics A, Campbell S, Eriksson I, Finlayson A, Fürst J, Garuoliene K, Gutiérrez-Ibarluzea I, Hviding K, Herholz H, Joppi R, Kalaba M, Laius O, Malinowska K, Pedersen HB, Markovic-Pekovic V, Piessnegger J, Selke G, Sermet C, Spillane S, Tomek D, Vončina L, Vlahović-Palčevski V, Wale J, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 10;5:109. doi: 10.3389/fphar.2014.00109. eCollection 2014. Review.

7.

Potentially inappropriate prescribing in elderly outpatients in Croatia.

Popović B, Quadranti NR, Matanović SM, Lisica ID, Ljubotina A, Duliba DP, Vlahović-Palčevski V.

Eur J Clin Pharmacol. 2014 Jun;70(6):737-44. doi: 10.1007/s00228-014-1667-0. Epub 2014 Mar 21.

PMID:
24647976
8.

Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs.

Matanović SM, Vlahović-Palčevski V.

Eur J Clin Pharmacol. 2014 Apr;70(4):483-90. doi: 10.1007/s00228-014-1648-3. Epub 2014 Jan 24.

PMID:
24458542
9.

Personalizing health care: feasibility and future implications.

Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL.

BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. Review.

10.

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013.

11.

Mycophenolate mofetil induced severe, life threatening lower gastrointestinal bleeding - case report.

Hauser G, Bubic I, Vlahovic-Palcevski V, Spanjol J, Stimac D.

Nefrologia. 2013 Jan 18;33(1):146-7. doi: 10.3265/Nefrologia.pre2012.Jun.11512. No abstract available.

12.

Potentially inappropriate medications in the elderly: a comprehensive protocol.

Mimica Matanović S, Vlahovic-Palcevski V.

Eur J Clin Pharmacol. 2012 Aug;68(8):1123-38. doi: 10.1007/s00228-012-1238-1. Epub 2012 Feb 24. Review.

PMID:
22362342
13.

Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.

Palčevski G, Skočibušić N, Vlahović-Palčevski V.

Eur J Clin Pharmacol. 2012 Jul;68(7):1073-7. doi: 10.1007/s00228-012-1221-x. Epub 2012 Feb 4.

PMID:
22307225
14.

Postmarketing surveillance.

Vlahović-Palčevski V, Mentzer D.

Handb Exp Pharmacol. 2011;205:339-51. doi: 10.1007/978-3-642-20195-0_17.

PMID:
21882120
15.

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future.

Vončina L, Strizrep T, Godman B, Bennie M, Bishop I, Campbell S, Vlahović-Palčevski V, Gustafsson LL.

Expert Rev Pharmacoecon Outcomes Res. 2011 Aug;11(4):469-79. doi: 10.1586/erp.11.42.

PMID:
21831028
16.

Health Alliance for prudent antibiotic prescribing in patients with respiratory tract infections (HAPPY AUDIT) -impact of a non-randomised multifaceted intervention programme.

Bjerrum L, Munck A, Gahrn-Hansen B, Hansen MP, Jarbol DE, Cordoba G, Llor C, Cots JM, Hernández S, López-Valcárcel BG, Pérez A, Caballero L, von der Heyde W, Radzeviciene R, Jurgutis A, Reutskiy A, Egorova E, Strandberg EL, Ovhed I, Mölstad S, Stichele RV, Benko R, Vlahovic-Palcevski V, Lionis C, Rønning M.

BMC Fam Pract. 2011 Jun 20;12:52. doi: 10.1186/1471-2296-12-52.

17.

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.

Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, McGinn D, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay FC, Vlahović-Palčevski V, Wendykowska K, Wettermark B, Zara C, Gustafsson LL.

Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):707-22. doi: 10.1586/erp.10.72.

PMID:
21155704
18.

Avoiding concomitant prescription of drugs with a potential for interaction: mission impossible?

Erdeljic V, Francetic I, Vlahovic-Palcevski V, Radosevic N, Makar-Ausperger K, Likic R.

Int J Clin Pharmacol Ther. 2010 Dec;48(12):821-9.

PMID:
21084038
19.

Reducing antibiotic use in Croatia.

Vlahović-Palčevski V.

Lancet Infect Dis. 2010 Oct;10(10):670-1. doi: 10.1016/S1473-3099(10)70212-7. No abstract available.

PMID:
20883964
20.

Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation.

Mimica Matanovic S, Bergman U, Vukovic D, Wettermark B, Vlahovic-Palcevski V.

Int J Antimicrob Agents. 2010 Oct;36(4):369-73. doi: 10.1016/j.ijantimicag.2010.05.019. Epub 2010 Aug 5.

PMID:
20688486
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk